Xilio Therapeutics 计划于2027年下半年公布转移性非小细胞肺癌患者初步1期数据

美股速递
Aug 12

Xilio Therapeutics 宣布,计划在2027年下半年公布其针对转移性非小细胞肺癌(NSCLC)患者的初步1期临床试验数据。这一消息标志着该公司在肿瘤治疗领域迈出了关键一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10